Part,  Chapter, Paragraph

 1   II,     5.  1.  1|          the most common cause of RRT for ESRD, affecting more
 2   II,     5.  7.Acr|    Quality and Outcomes Framework~RRT~Renal Replacement Therapy~
 3   II,     5.  7.  1|        renal replacement therapy (RRT) for ESRD in children are
 4   II,     5.  7.  2|          in patients with ESRD on RRT. Available data on the prevalence
 5   II,     5.  7.  2|       incidence and prevalence of RRT for ESRD to the ERA-EDTA
 6   II,     5.  7.  2|  incidence and prevalence data on RRT were used from 42 registries
 7   II,     5.  7.  2|          of each patient starting RRT in their coverage area together
 8   II,     5.  7.  2|        the start date and type of RRT. During follow-up of the
 9   II,     5.  7.  2|          their countries, data on RRT over the period 1992-2005
10   II,     5.  7.  2|     included patients who started RRT over the period 1996-2000
11   II,     5.  7.  3|        2005 the incidence rate of RRT for ESRD in children aged
12   II,     5.  7.  3|       2005 the incidence rates of RRT for ESRD ranged from 57
13   II,     5.  7.  3| prevalence, the incidence rate of RRT for ESRD in 2005 steeply
14   II,     5.  7.  3|         Table 5.7.3. Incidence of RRT over the 1992-2005 period
15   II,     5.  7.  3|         Table 5.7.4. Incidence of RRT over the 1992-2005 period
16   II,     5.  7.  3|         Table 5.7.5. Incidence of RRT over the 2000-2005 period
17   II,     5.  7.  3|      period the incidence rate of RRT increased by more than 50% (
18   II,     5.  7.  3|          Whereas the incidence of RRT for diabetic and hypertensive
19   II,     5.  7.  3|         as high, the incidence of RRT for ESRD due to glomerulonephritis/
20   II,     5.  7.  3|       absolute incidence rates of RRT for ESRD across countries,
21   II,     5.  7.  3|         in the incidence rates of RRT for diabetic and hypertensive
22   II,     5.  7.  3|       improvements in survival of RRT patients (Jager and van
23   II,     5.  7.  3|     increase in the prevalence of RRT over the past decades that
24   II,     5.  7.  3|  prevalence the incidence rate of RRT was higher in socially deprived
25   II,     5.  7.  3|     prevalence of ESRD undergoing RRT in children (<20 years)
26   II,     5.  7.  3|         In 2005 the prevalence of RRT in the 0-14 years age group
27   II,     5.  7.  3|           the crude prevalence of RRT for ESRD varied from 321
28   II,     5.  7.  3|       Table 5.7.7). Prevalence of RRT in Europeans is lower than
29   II,     5.  7.  3|       Table 5.7.6A. Prevalence of RRT over the period 1992-2005
30   II,     5.  7.  3|       Table 5.7.6B. Prevalence of RRT over the period 2000-2005
31   II,     5.  7.  3|        Table 5.7.7. Prevalence of RRT over the period 1992-2005
32   II,     5.  7.  3|    overall adjusted prevalence of RRT for ESRD increased from
33   II,     5.  7.  3|       mortality rates in incident RRT patients are 52% in all
34   II,     5.  7.  3|        respectively.~Mortality on RRT is lower in Europe compared
35   II,     5.  7.  3|       mortality rates in incident RRT patients per age group,
36   II,     5.  7.  3|       absolute incidence rates of RRT for ESRD across countries,
37   II,     5.  7.  3|         in the incidence rates of RRT for diabetic and hypertensive
38   II,     5.  7.  3|       improvements in survival of RRT patients (Jager and van
39   II,     5.  7.  3|     increase in the prevalence of RRT over the past decades that
40   II,     5.  7.  3|   selection bias, the survival of RRT patients could be considerably
41   II,     5.  7.  4|          2003), the prevalence of RRT was higher in socially deprived
42   II,     5.  7.  4|          the most common cause of RRT for ESRD, affecting more
43   II,     5.  7.  4|         in the incidence rates of RRT for diabetic ESRD and differences
44   II,     5.  7.  4|        overall incidence rates of RRT between Member States are
45   II,     5.  7.  4|         unknown. The incidence of RRT is the outcome of a complex
46   II,     5.  7.  4|          or may not be taken into RRT. There are no data available
47   II,     5.  7.  4|      hypothesis of restriction of RRT, at least not in Western
48   II,     5.  7.  5|           improvement program for RRT, administered by the Danish
49   II,     5.  7.  5|           patients should receive RRT when deemed necessary. The
50   II,     5.  7.  5|           2002 new regulations on RRT, established that planning
51   II,     5.  7.  5|           quantity and quality of RRT care using electronic methods
52   II,     5.  7.  5|            In the Czech Republic, RRT is freely available for
53   II,     5.  7.  5|         health policies on CKD or RRT in Estonia and Sweden. We
54   II,     5.  7.  5|         performance indicators in RRT comparable at international
55   II,     5.  7.  6|         performance indicators in RRT. The availability of these
56   II,     5.  7.  6|         health policies regarding RRT for ESRD. In contrast, only